dental anxiety disorder, hyperactive gag reflex, arterial hypertension, and related conditions
Conditions
Interventions
None listed
Sponsors
Institute of Science Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who received intravenous sedation for dental treatment between August 2023 and March 2024.
Exclusion criteria
Exclusion criteria: Patients with intellectual disabilities and those who have difficulty responding to the questionnaire.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Satisfaction Survey(11-point scale: 0-10) | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety levels pre- and post-treatment (numeric rating scale), sedation depth during procedure (modified observer's assessment of alertness/sedation; MOAA/S score), sedative dosage, patient background information. | — |
Countries
Japan
Contacts
Public ContactShigeru Maeda
Graduate School of Medical and Dental Science, Institute of Science Tokyo Department of Dental Anesthesiology
Outcome results
None listed